Insider Profile
Hennigar, David John
3
Companies Filed At
5
Open-Market Buys (2yr)
$348K
Buy Value (2yr, open-market)
Jun 30, 2026
Most Recent Trade
| Date | Company | Dir. | Value |
|---|---|---|---|
| Jun 30, 2026 |
$HLF
High Liner Foods Incorporated
|
Buy | $9K |
| Mar 10, 2026 |
$MDX
MedX Health Corp.
|
Buy | $22K |
| Mar 05, 2026 |
$MDX
MedX Health Corp.
|
Buy | — |
| Mar 05, 2026 |
$CAN
Canadian Gold Resources Ltd.
|
Buy | — |
| Feb 27, 2026 |
$MDX
MedX Health Corp.
|
Sell | — |
| Oct 03, 2025 |
$CAN
Canadian Gold Resources Ltd.
|
Buy | $117K |
| Oct 02, 2025 |
$MDX
MedX Health Corp.
|
Sell | $120K |
| Oct 02, 2025 |
$MDX
MedX Health Corp.
|
Sell | — |
| Oct 02, 2025 |
$CAN
Canadian Gold Resources Ltd.
|
Buy | $2K |
| Sep 29, 2025 |
$CAN
Canadian Gold Resources Ltd.
|
Buy | $6K |
| Sep 11, 2025 |
$CAN
Canadian Gold Resources Ltd.
|
Buy | $200K |
| Jun 06, 2025 |
$MDX
MedX Health Corp.
|
Sell | $158K |
| Jun 06, 2025 |
$MDX
MedX Health Corp.
|
Sell | — |
| Mar 24, 2025 |
$MDX
MedX Health Corp.
|
Sell | $1.8M |
| Mar 24, 2025 |
$MDX
MedX Health Corp.
|
Sell | $1.8M |
| Dec 31, 2024 |
$MDX
MedX Health Corp.
|
Sell | — |
| Jul 25, 2024 |
$MDX
MedX Health Corp.
|
Buy | $1K |
| Jul 25, 2024 |
$MDX
MedX Health Corp.
|
Buy | $1K |
| Jul 25, 2024 |
$MDX
MedX Health Corp.
|
Buy | $2K |
| Jul 25, 2024 |
$MDX
MedX Health Corp.
|
Buy | $6K |
| Jul 24, 2024 |
$MDX
MedX Health Corp.
|
Buy | $39K |
| Jul 24, 2024 |
$MDX
MedX Health Corp.
|
Buy | $5K |
| Jul 24, 2024 |
$MDX
MedX Health Corp.
|
Buy | $39K |
| Mar 26, 2024 |
$MDX
MedX Health Corp.
|
Buy | $7K |
| Nov 17, 2023 |
$MDX
MedX Health Corp.
|
Sell | — |
| Nov 17, 2023 |
$MDX
MedX Health Corp.
|
Buy | — |
| Nov 17, 2023 |
$MDX
MedX Health Corp.
|
Buy | $1.5M |
| Sep 07, 2023 |
$MDX
MedX Health Corp.
|
Sell | $300K |
| Sep 07, 2023 |
$MDX
MedX Health Corp.
|
Sell | — |
| Jun 26, 2023 |
$MDX
MedX Health Corp.
|
Buy | $15K |
| May 09, 2023 |
$MDX
MedX Health Corp.
|
Sell | — |
| May 05, 2023 |
$MDX
MedX Health Corp.
|
Buy | — |
| Jan 13, 2022 |
$MDX
MedX Health Corp.
|
Buy | $124K |
Muted rows are plan purchases, compensation grants, or DRIP — not open-market.
Confluence Scores reflect the company's current score, not the score at time of trade.